These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10844926)

  • 21. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senate passes bill requiring disclosure of health care workers' HIV status, RN first assistant reimbursement issue continues.
    Cruz LD
    AORN J; 1991 Sep; 54(3):607-9, 612. PubMed ID: 1952891
    [No Abstract]   [Full Text] [Related]  

  • 23. Curtailed Canadian HIV compensation.
    Kondro W
    Lancet; 1994 Mar; 343(8900):783-4. PubMed ID: 7907739
    [No Abstract]   [Full Text] [Related]  

  • 24. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.
    Donegan E; Stuart M; Niland JC; Sacks HS; Azen SP; Dietrich SL; Faucett C; Fletcher MA; Kleinman SH; Operskalski EA
    Ann Intern Med; 1990 Nov; 113(10):733-9. PubMed ID: 2240875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis on late HIV diagnosis among newly reported human immunodeficiency virus/acquired immunodeficiency syndrome cases between 2009 and 2017 in medical institutions].
    Yue Q; Liu YF; Li J; Zang CP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Dec; 52(12):1248-1253. PubMed ID: 30522225
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases.
    Kinloch-de Loës S; de Saussure P; Saurat JH; Stalder H; Hirschel B; Perrin LH
    Clin Infect Dis; 1993 Jul; 17(1):59-65. PubMed ID: 8353247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA and other host factors in transfusion-acquired HIV-1 infection.
    Geczy AF; Kuipers H; Coolen M; Ashton LJ; Kennedy C; Ng G; Dodd R; Wallace R; Le T; Raynes-Greenow CH; Dyer WB; Learmont JC; Sullivan JS
    Hum Immunol; 2000 Feb; 61(2):172-6. PubMed ID: 10717811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. California HIV confidentiality code prevents deposition of blood donors.
    J Health Hosp Law; 1991 Nov; 24(11):344-5. PubMed ID: 10183540
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of sickle cell disease on susceptibility to HIV infection.
    Kelly S; Jacobs ES; Stone M; Keating SM; Lee TH; Chafets D; Heitman J; Dimapasoc M; Operskalski E; Hagar W; Vichinsky E; Busch MP; Norris PJ; Custer B;
    PLoS One; 2020; 15(4):e0218880. PubMed ID: 32267841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.
    Learmont J; Tindall B; Evans L; Cunningham A; Cunningham P; Wells J; Penny R; Kaldor J; Cooper DA
    Lancet; 1992 Oct; 340(8824):863-7. PubMed ID: 1357294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of HIV infection in hemophilic adults.
    Sanders NL
    Prog Clin Biol Res; 1990; 324():93-9. PubMed ID: 2408058
    [No Abstract]   [Full Text] [Related]  

  • 32. Serologic test for syphilis: a discredited surrogate test for HIV infection.
    Case J
    Transfusion; 1998 Feb; 38(2):218. PubMed ID: 9531957
    [No Abstract]   [Full Text] [Related]  

  • 33. Mode of transmission of HIV-1 in Saudi Arabia.
    Alrajhi AA; Halim MA; Al-Abdely HM
    AIDS; 2004 Jul; 18(10):1478-80. PubMed ID: 15199329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire.
    Shaffer N; Hedberg K; Davachi F; Lyamba B; Breman JG; Masisa OS; Behets F; Hightower A; Nguyen-Dinh P
    AIDS; 1990 Dec; 4(12):1231-6. PubMed ID: 2088400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Viral seroprevalence, transfusion and alloimmunization in adults with sickle cell anemia in Guadeloupe].
    Le Turdu-Chicot C; Foucan L; Etienne-Julan-Otto M
    Transfus Clin Biol; 2002 Apr; 9(2):115-20. PubMed ID: 12058554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for HIV-2 infection in Guinea-Bissau.
    Harrison LH; da Silva AP; Gayle HD; Albino P; George R; Lee-Thomas S; Rayfield MA; Del Castillo F; Heyward WL
    J Acquir Immune Defic Syndr (1988); 1991; 4(11):1155-60. PubMed ID: 1753343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion transmitted human T-lymphotropic virus infections.
    Grillner L
    Acta Anaesthesiol Scand Suppl; 1988; 89():16-9. PubMed ID: 3067484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and prevention of transfusion-associated human immunodeficiency virus transmission in sub-Saharan Africa.
    McFarland W; Mvere D; Shandera W; Reingold A
    Vox Sang; 1997; 72(2):85-92. PubMed ID: 9088075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of HIV screening of blood transfusions in Zambia.
    Foster S; Buvé A
    Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group.
    Regan FA; Hewitt P; Barbara JA; Contreras M
    BMJ; 2000 Feb; 320(7232):403-6. PubMed ID: 10669443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.